lifestyle.digitaladblog.com

Travere Therapeutics Provides Update on FDA Advisory Committee Meeting for FILSPARI® (sparsentan) in FSGS

Travere Therapeutics Provides Update on FDA Advisory Committee Meeting for FILSPARI® (sparsentan) in FSGS – NEWSnet – News… as it used to be

More Press Releases

May 7, 2026

Personalis Reports First Quarter Results and Recent Highlights

May 7, 2026

Logitech Completes $1.6 Billion Share Buyback and Launches New $1.4 Billion Program

May 7, 2026

NuScale Power Reports First Quarter 2026 Results

May 7, 2026

Covista Third Quarter Fiscal Year 2026 Results; Raises Fiscal Year 2026 Revenue and Adjusted Earnings Per Share Guidance